Muscarinic receptor oligomerization.

about

Muscarinic receptor oligomerization.

Item

http://www.wikidata.org/entity/Q47394323

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Muscarinic receptor oligomerization.

@en

Muscarinic receptor oligomerization.

@nl

type

Item

label

Muscarinic receptor oligomerization.

@en

Muscarinic receptor oligomerization.

@nl

prefLabel

Muscarinic receptor oligomerization.

@en

Muscarinic receptor oligomerization.

@nl

P1476

Muscarinic receptor oligomerization

@en

P2093

Elisa Alvarez-Curto

http://www.w3.org/2001/XMLSchema#string

Richard J Ward

http://www.w3.org/2001/XMLSchema#string

Sara Marsango

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors

Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist states

G-protein-coupled receptor heterodimerization modulates receptor function

Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist

Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes

Crystal structure of the β2 adrenergic receptor-Gs protein complex

Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization

The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist

High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor

Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor Heteromerization

P304

401-410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROPHARM.2017.11.023

http://www.w3.org/2001/XMLSchema#string

P433

Pt C

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P50

Graeme Milligan

P577

2017-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29146505

http://www.w3.org/2001/XMLSchema#string

P921

cell surface receptor

membrane proteins

P932

6078712

http://www.w3.org/2001/XMLSchema#string